1. Houten, Sander M, Te Brinke, Heleen, Denis, Simone, Wanders, Ronald Ja, Duran, Marinus. 2013. Genetic basis of hyperlysinemia. In Orphanet journal of rare diseases, 8, 57. doi:10.1186/1750-1172-8-57. https://pubmed.ncbi.nlm.nih.gov/23570448/
2. Marinella, G, Pascarella, F, Vetro, A, Orsini, A, Battini, R. 2024. Hyperlysinemia, an ultrarare inborn error of metabolism: Review and update. In Seizure, 120, 135-141. doi:10.1016/j.seizure.2024.06.020. https://pubmed.ncbi.nlm.nih.gov/38991296/
3. Guo, Ye, Wu, Junjie, Wang, Min, Yang, Chonglin, Guo, Weixiang. 2022. The Metabolite Saccharopine Impairs Neuronal Development by Inhibiting the Neurotrophic Function of Glucose-6-Phosphate Isomerase. In The Journal of neuroscience : the official journal of the Society for Neuroscience, 42, 2631-2646. doi:10.1523/JNEUROSCI.1459-21.2022. https://pubmed.ncbi.nlm.nih.gov/35135854/
4. Yan, Qiaofang, Du, Yuanyuan, Huang, Fei, Han, Liqiao, Huang, Xianzhang. 2024. Identification of mitochondria-related genes as diagnostic biomarkers for diabetic nephropathy and their correlation with immune infiltration: New insights from bioinformatics analysis. In International immunopharmacology, 142, 113114. doi:10.1016/j.intimp.2024.113114. https://pubmed.ncbi.nlm.nih.gov/39265357/
5. Lutter, Dominik, Sachs, Stephan, Walter, Marc, Bergman, Bryan C, Hofmann, Susanna M. 2023. Skeletal muscle and intermuscular adipose tissue gene expression profiling identifies new biomarkers with prognostic significance for insulin resistance progression and intervention response. In Diabetologia, 66, 873-883. doi:10.1007/s00125-023-05874-y. https://pubmed.ncbi.nlm.nih.gov/36790478/
智鼠故事 
